SCHEMBL22984907

SCHEMBL22984907

Cc1cc(Cl)c(O)cc1C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
ALOX15 P16050 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
CYP1A2 P05177 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
TP53 P04637 4/20 0.43
CYP2C9 P11712 4/20 0.43
CYP2C19 P33261 3/20 0.43
HIF1A Q16665 2/20 0.43
TSHR P16473 4/20 0.42
CYP3A4 P08684 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TYR P14679 2/20 0.41
CA2 P00918 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16736848 0.83 ALOX15 (0.52) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL9503098 0.82 ALDH1A1 (0.71) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL10907968 0.82 ALDH1A1 (0.56) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL23542362 0.81 ALOX15 (0.62) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL12162725 0.81 SMN1; SMN2 (0.44) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL627857 0.79 ALOX15 (0.75) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL29414126 0.79 ALOX15 (0.75) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL931843 0.79 ALOX15 (0.59) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL23811949 0.79 SMN1; SMN2 (0.38) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E
SCHEMBL13145524 0.79 CD44 (0.42) ALDH1A1ALOX15SMN1; SMN2CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919850-B2 Covalent inhibitors of KRas G12C ARAXES PHARMA LLC (US) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919850-B2 Covalent inhibitors of KRas G12C KRAS, NRAS, HRAS ALDH1A1 2706/4885ALOX15 4571/4885SMN1; SMN2 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.